Viant Medical Acquires Meraqi Medical to Advance Bioelectronics and Interventional Technology Capabilities

On September 16, 2019, VCBeat (WeChat ID: vcbeat) learned from foreign media reports that medical device company

Viant Medical (Viant) Announces Acquisition of Meraqi Medical (Meraqi). No financial terms of the acquisition were disclosed.

Reportedly, this marks Viant’s fourth acquisition within two years. Viant will continue to expand its expertise and capabilities in the healthcare market, advancing the front-end design and development of Interventional Technology and Bioelectronics products, thereby delivering end-to-end solutions for its customers.

Bioelectronics applies the theories and technologies of electronic information science to address biological problems, including the acquisition and analysis of biological information, the development of biomedical detection and adjunctive therapeutic technologies based on nanotechnology, and the development of miniature diagnostic instruments.

Interventional techniques, also known as interventional therapy, refer to minimally invasive treatments performed under the guidance and monitoring of imaging equipment such as digital subtraction angiography (DSA), CT, ultrasound, or magnetic resonance imaging. By using puncture needles, catheters, and other interventional devices, specific instruments are introduced to the lesion site through natural body orifices or tiny incisions to treat patients.

Headquartered in Silicon Valley, USA, and founded by industry veterans, Meraqi is a medical device design, development, and manufacturing company. The company obtained ISO (International Organization for Standardization) certification in 2018. Meraqi is dedicated to developing innovative devices, bringing new products and technologies to patients and clinicians.

Leveraging decades of comprehensive experience, the Meraqi team has made significant strides in bioelectronics and minimally invasive interventional devices, with notable achievements particularly in the research and development of single-use interventional devices.

Headquartered in Massachusetts, USA, Viant is a leading medical device company. With nearly 6,000 employees across 24 countries and regions worldwide, the company is dedicated to enhancing the quality of medical devices and advancing the market development of precision medical devices.

Viant Appoints Alton E. Shader as CEO to Accelerate Strategic ExpansionRecently, Viant announced the appointment of medical device industry veteran Alton E. Shader as Chief Executive Officer to accelerate the company’s strategic expansion. The company combines its deep expertise with experience in design, manufacturing, and packaging to develop innovative medical technology solutions.

Since partnering with healthcare company Water Street and private equity firm JLL Partners in 2016, Viant has grown into one of the world’s leading contract manufacturers of medical devices.

Upon completion of this acquisition, Meraqi will be integrated into Viant’s centers and its global Design and Development (D&D) manufacturing bases. Viant will incorporate Meraqi’s engineering expertise and design capabilities into its solutions to optimize the supply chain, control costs, and enhance product quality. Meanwhile, this acquisition will also facilitate the development of Viant’s minimally invasive surgical platform.

Viant President Declan Smyth stated, “Meraqi possesses deep technical expertise, and this acquisition will help us develop new products to more comprehensively meet customers’ medical needs.”

(Compiled by Xu Xiaoxue)